Antonio - Medical Affairs Executive with 15+ years in Pharma and Healthcare
Resumen
An accomplished medical professional specializing in medical leadership, regulatory compliance, and stakeholder engagement with extensive experience in global pharmaceutical companies and public health initiatives.
Logros Clave
- Managed a team of over 40 FTEs, promoting key members to senior positions, and maintained a 95% team retention rate during organizational restructuring.
Habilidades
Directed medical teams and cross-functional collaborations to drive organizational goals and strategic initiatives.
Ensured timely approvals with regulatory agencies such as COFEPRIS and maintained compliance in pharmacovigilance audits.
Built and strengthened relationships with KOLs, stakeholders, and healthcare professionals to support medical and commercial strategies.
Led multiple initiatives including product launches, digital platform development, and organizational restructuring.
Coordinated public health strategies and contributed to surveillance programs for HIV/AIDS and STDs at the national level.
Idiomas
Experiencia
Country Medical Chair / Country Medical Lead Speciality Care
Sanofi, Mexico
Led the SPECTRUM transformation project, enhancing global medical alignment., Launched MedVox, the first in-country digital MSL engagement platform, improving stakeholder interaction by 30%., Pioneered the Volcano joint effort with MedExc Manager, refining HCP engagement and diagnostics., Successfully led SEC audit with zero major findings., Managed and developed a team of over 40 FTEs, promoting key members to senior positions., Effectively negotiated the inclusion of SPC products into the National formulary.
Country Medical Chair / Country Medical Director Pharma
Sanofi, Mexico
Orchestrated integration of GenMed and SPC medical affairs teams, improving efficiency by 20%., Acted as spokesperson during the COVID-19 pandemic, implementing strategies that minimized hydroxychloroquine misuse by 40%., Strengthened KOL relationships, increasing stakeholder involvement by 15%., Ensured business continuity during significant organizational restructuring, maintaining a 95% team retention rate.
Medical Director / Medical Head – Rare Diseases, Immunology, Oncology, Renal, and Multiple Sclerosis
Sanofi Genzyme, Mexico
Provided comprehensive medical guidance, boosting cross-functional collaboration by 20%., Streamlined approval processes with COFEPRIS, reducing time-to-market by 3 months., Enhanced investigator engagement, increasing study participation rates by 35%., Achieved a 100% compliance rate in pharmacovigilance audits.
Senior Medical Manager for Neuroscience & Lysosomal Storage Diseases
Genzyme/ Genzyme, a Sanofi Company, Mexico
Prepared launch dossiers, resulting in a 15% increase in market adoption rates., Achieved significant cost savings, reducing diagnostic costs by 70%., Fostered effective collaboration, ensuring cohesive strategy and execution.
Medical Manager for Anti-infectives and Ophthalmology
Pfizer, Mexico
Developed and implemented marketing strategies, ensuring compliance and relevance., Planned CME activities and training sessions, enhancing sales representative knowledge., Built and maintained strong relationships with KOLs, supporting product positioning.
Medical Marketing Liaisons Scientist (Cardiology Portfolio)
Kept KOLs informed on medical product information, reinforcing key messages and strategies., Relayed KOL feedback to marketing and sales teams, strengthening strategic alignment.
Doctor
George Eliot Hospital, Nuneaton, UK
Assisted sub-specialists in the Diabetes clinic, ensuring high-quality patient care and follow-up.
Assistant to the Director for the National HIV/AIDS and other STD’s Surveillance Program
Ministry of Health, Epidemiological Surveillance Office, Mexico
Coordinated public health strategies and resources for HIV/AIDS and other STD surveillance., Provided detailed public health information for strategic decision-making.
Educacion
Interna,onal Federa,tion of Associa,ons of Pharmaceu,cal Physicians & Pharmaceu,ical Medicine (IFAPP) and King’s College
Medical Affairs in Medicines Development and Professional Certification in Medicines Development (CMD)